Learning Center
FDA Status:
510k Class II Cleared for the Treatment of Diabetic Foot Ulcers (DFUs).
510k Class I Pending for Relief of Minor Muscle Aches and Pains, Temporary Increase in Local Blood Circulation, and Activation of Connective Tissue.
Filter by Category
Filter by Category
Filter by Resource Type
CS-Pro MED Studies
Veterinary
Featured Literature
Veterinary
In military cadets with MTSS (shin splints), A single application of focused shockwave treatment improved mean run time after four weeks to 17 min 33 sec, compared to 4 min 48 sec in the exercise-only group.
Both f-ESWT and r-ESWT are effective at alleviating pain and improving physical functions, knee range of motion, and the 6-minute walk test distance in patients with knee OA. The f-ESWT yielded a greater reduction in pain and improvements in physical function and the 6-minute walk test distance compared with r-ESWT.
ESWT is an effective therapeutic modality in combination with standard care for neuropathic diabetic foot ulcers that do not respond to standard care alone.
A meta-analysis of seven randomized controlled trials demonstrated that the treatment of ED with Li-ESWT resulted in a significant increase in International Index of Erectile Function scores.
Studies by application
Aesthetics
Not FDA cleared for this intended use
Men's Urology
Not FDA cleared for this intended use
Orthopedics
Not FDA cleared for this intended use
PRP Activation
Not FDA cleared for this intended use
Wound Care
Cleared by the FDA for treatment of diabetic foot ulcer wounds
CS-Pro MED Studies
Human
“Not FDA cleared for this intended use.
Featured Literature
Human
Not FDA cleared for this intended use.
In military cadets with MTSS (shin splints), A single application of focused shockwave treatment improved mean run time after four weeks to 17 min 33 sec, compared to 4 min 48 sec in the exercise-only group.
Both f-ESWT and r-ESWT are effective at alleviating pain and improving physical functions, knee range of motion, and the 6-minute walk test distance in patients with knee OA. The f-ESWT yielded a greater reduction in pain and improvements in physical function and the 6-minute walk test distance compared with r-ESWT.
Human
Not FDA cleared for this intended use.
ESWT is an effective therapeutic modality in combination with standard care for neuropathic diabetic foot ulcers that do not respond to standard care alone.
A meta-analysis of seven randomized controlled trials demonstrated that the treatment of ED with Li-ESWT resulted in a significant increase in International Index of Erectile Function scores.
Studies by application
Aesthetics
Not FDA cleared for this intended use
orthopedics
Not FDA cleared for this intended use
Men's urology
Not FDA cleared for this intended use
PRP Activation
Not FDA cleared for this intended use
wound care
Not FDA cleared for this intended use
